Max Bayer / endpoints - Novo Nordisk submitted a higher dose of its obesity drug Wegovy for FDA approval and is using a recently-won voucher to expedite the review. The company said Wednesday that it submitted ...
#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #publichealth #biotech #drugdevelopment #fda
Saturday, November 29, 2025, 5:21 pm / permalink 16400 / 2 stories in 3 months
oncodaily - The landscape of early-stage pancreatic ductal adenocarcinoma (PDAC) continues to evolve as clinicians move from surgery-first strategies toward perioperative treatment. Neoadjuvant and perioperative approaches have shown growing promise, yet no […]
#healthcare #pharmaceuticals #publichealth #drugdevelopment
Saturday, November 29, 2025, 9:21 am / permalink 16387 / 5 stories in 3 months
medicalxpress - Imagine you're 83 years old, living with dementia in a long-term care home. Lately, your caregivers keep asking you to wear a bracelet on your wrist 24/7. They say it's for your safety, so they can locate you quickly when needed.
Saturday, November 29, 2025, 5:21 am / permalink 16384 / 2 stories in 3 months
Judge orders Leapfrog to remove safety grades for five Florida hospitals 3 stories in 21.1 hours
Daily multivitamin slows epigenetic aging in randomized COSMOS analysis 4 stories in 40.1 hours
Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity 6 stories in 54.2 hours
White House briefing triggered rapid drops in acetaminophen use in ERs 2 stories in 58.1 hours
MUSC Health buys large South Carolina multispecialty practice for $111M 4 stories in 58.2 hours
Eli Lilly launches Employer Connect to broaden GLP‑1 coverage 16 stories in 83.2 hours
Analysis finds small patient group drives majority of admissions and costs 2 stories in 83.2 hours
Springing forward worsens sleep and sparks health complaints 8 stories in 87.2 hours
Cancer Grand Challenges awards five teams bold funding for cancer research 67 stories in 94.2 hours
Belzutifan combinations highlighted at ASCO GU improve RCC outcomes 3 stories in 96.2 hours
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.
Bluesky: